EMR and RAC Audits: Who Takes the Hit? Part II

Monday, Feb. 12, 2018
Special News Broadcast
10-10:30 a.m. EST; 7-7:30 a.m. PST


SPECIAL GUEST
Mary A. Inman, Esq.
Whistleblower Attorney
 Constantine Cannon


FEATURING
Nancy Beckley, MS, MBA, CHC; David Glaser, Esq.;
Ronald Hirsch, MD, FACP, CHCQM;
Timothy Powell, CPA; and J. Paul Spencer, CPC, CPC-H


Who bears the burden and blame of regulatory noncompliance when your facility relies on non-medical software companies that create electronic medical records? We will continue with the second part of this developing story during the next edition of Monitor Mondays, when whistleblower attorney Mary Inman will report on an ongoing qui tam action under the federal False Claims Act through which a relator alleges that Bon Secours Health System, Inc. fraudulently billed Medicare and Medicaid millions of dollars. Inman is also expected to report on other current whistleblower cases.

The broadcast rundown also will include:

  • Monday Rounds: Ronald Hirsch, MD, vice president of R1 Physician Advisory Services, will be making his Monday Rounds with another installment of his popular segment.

  • Hot Topics: Monitor Mondays senior correspondent Nancy Beckley, president and CEO for Nancy Beckley and Associates, will have all the latest developments on the therapy caps. She will also have the Monitor Mondays Listener Survey.

  • Medicare Advantage Report: Monitor Mondays national correspondent J. Paul Spencer will continue to report on the vexing issue of Medicare Advantage. Spencer is a senior healthcare consultant for DoctorsManagement.

  • Risky Business: Healthcare attorney David Glaser with Fredrikson & Byron will report on a recent memo from the U.S. Department of Justice offering good news for some providers.

  • 340B Drug Update: RACmonitor national correspondent Timothy Powell, CPA, will report on the latest developments regarding the 340B drug discount program.


Register now for this special news broadcast coming up at 10 a.m. EST on Monday, Feb. 12. 

Monitor with us.™